1.Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study.
Chang Yun YOON ; Misol LEE ; Seung Up KIM ; Hyunsun LIM ; Tae Ik CHANG ; Youn Kyung KEE ; Seung Gyu HAN ; In Mee HAN ; Young Eun KWON ; Kyoung Sook PARK ; Mi Jung LEE ; Jung Tak PARK ; Seung Hyeok HAN ; Sang Hoon AHN ; Shin Wook KANG ; Tae Hyun YOO
Kidney Research and Clinical Practice 2017;36(1):48-57
BACKGROUND: Hepatic steatosis measured with controlled attenuation parameter (CAP) using transient elastography predicts metabolic syndrome in the general population. We investigated whether CAP predicted metabolic syndrome in chronic kidney disease patients. METHODS: CAP was measured with transient elastography in 465 predialysis chronic kidney disease patients (mean age, 57.5 years). RESULTS: The median CAP value was 239 (202–274) dB/m. In 195 (41.9%) patients with metabolic syndrome, diabetes mellitus was more prevalent (105 [53.8%] vs. 71 [26.3%], P < 0.001), with significantly increased urine albumin-to-creatinine ratio (184 [38–706] vs. 56 [16–408] mg/g Cr, P = 0.003), high sensitivity C-reactive protein levels (5.4 [1.4–28.2] vs. 1.7 [0.6–9.9] mg/L, P < 0.001), and CAP (248 [210–302] vs. 226 [196–259] dB/m, P < 0.001). In multiple linear regression analysis, CAP was independently related to body mass index (β = 0.742, P < 0.001), triglyceride levels (β = 2.034, P < 0.001), estimated glomerular filtration rate (β = 0.316, P = 0.001), serum albumin (β = 1.386, P < 0.001), alanine aminotransferase (β = 0.064, P = 0.029), and total bilirubin (β = −0.881, P = 0.009). In multiple logistic regression analysis, increased CAP was independently associated with increased metabolic syndrome risk (per 10 dB/m increase; odds ratio, 1.093; 95% confidence interval, 1.009–1.183; P = 0.029) even after adjusting for multiple confounding factors. CONCLUSION: Increased CAP measured with transient elastography significantly correlated with and could predict increased metabolic syndrome risk in chronic kidney disease patients.
Alanine Transaminase
;
Bilirubin
;
Body Mass Index
;
C-Reactive Protein
;
Diabetes Mellitus
;
Elasticity Imaging Techniques
;
Fatty Liver*
;
Glomerular Filtration Rate
;
Humans
;
Linear Models
;
Logistic Models
;
Odds Ratio
;
Renal Insufficiency, Chronic*
;
Serum Albumin
;
Triglycerides
2.Comparison of characteristics in patients with both thyroid and breast cancer: Based on order of incidence
Joo Heung KIM ; Incheon KANG ; Sanggeun NAM ; Hyung Seok PARK ; Seho PARK ; Jong Ju JEONG ; Kee Hyun NAM ; Woong Youn CHUNG ; Seung Il KIM ; Young Up CHO ; Byeong Woo PARK
Korean Journal of Clinical Oncology 2017;13(1):1-9
PURPOSE: Clinicopathologic characteristics of patients with both thyroid and breast cancer during their lifetime were analyzed to investigate the association between the two malignancies according to the order of incidence.METHODS: A total of 405 patients who underwent surgery for breast and thyroid cancer at Severance Hospital between 1995 and 2014 were retrospectively selected and classified into 3 groups according to the order of incidence of the two cancers: simultaneous cancer (S), thyroid cancer followed by breast cancer (TB), and breast cancer followed by thyroid cancer (BT). Univariate analysis was conducted to compare parameters.RESULTS: S, TB, and BT groups were 166 (41.0%), 96 (23.7%), and 143 (35.3%) patients, respectively. In TB and BT groups, tumor size and surgical site for secondary cancer were smaller; therefore, adjuvant treatments were less frequently required for secondary cancer. ER positive rate was 77.1% in S, 75% in TB, and 63.7% in BT groups (P=0.027). The ratio of ER negative was higher in the group with BRAF mutation. Survival rate for index tumor was higher in order from TB, and BT, followed by S groups without statistical difference.CONCLUSION: It is difficult to find a significant difference according to the order of occurrence except by screening test, and more studies are needed in the future. Establishing an appropriate screening program is important in order to detect secondary breast or thyroid cancer after surgery for thyroid or breast cancer.
Breast Neoplasms
;
Breast
;
Humans
;
Incidence
;
Mass Screening
;
Neoplasms, Second Primary
;
Retrospective Studies
;
Survival Rate
;
Thyroid Gland
;
Thyroid Neoplasms
3.Is Endoscopic Resection for Type 1 Gastric Neuroendocrine Tumors Essential for Treatment?: Multicenter, Retrospective Long-term Follow-up Results.
Han Sol LEE ; Seong Woo JEON ; Gwang Ha KIM ; Jin Il KIM ; Il Kwun CHUNG ; Sam Ryong JEE ; Heung Up KIM ; Geom Seog SEO ; Gwang Ho BAIK ; Kee Don CHOI ; Jeong Seop MOON
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016;16(1):13-18
BACKGROUND/AIMS: Treatment of gastric neuroendocrine tumors is determined by type and size of the lesion. This study aimed to compare the long-term efficacy of observation and endoscopic resection for type 1 gastric neuroendocrine tumors without metastasis. MATERIALS AND METHODS: Among the 223 cases of gastric neuroendocrine tumors diagnosed between January 1996 and December 2011, 104 cases were type 1 gastric neuroendocrine tumors. Sixty-seven patients were treated endoscopically and 27 patients were observed without treatment. Endoscopic mucosal resection, endoscopic submucosal dissection, and polypectomy were the methods used for endoscopic treatment. Therapeutic efficacy and rates of complication and recurrence were evaluated retrospectively. RESULTS: In the endoscopic resection group, complete resection was observed in 53 patients (79.1%), and recurrence was observed in 14 patients (20.9%). On analysis of the observation group, no change was observed in 19 patients (70.4%), and tumor progression was observed in 8 patients (29.6%). Median follow-up duration was 49 months (31~210 months). No mortality was reported in either group during follow-up. CONCLUSIONS: Observation of type 1 gastric neuroendocrine tumors without metastasis yields results similar to those produced by endoscopic resection. Observation alone may be a safe treatment.
Endoscopy
;
Follow-Up Studies*
;
Humans
;
Mortality
;
Neoplasm Metastasis
;
Neuroendocrine Tumors*
;
Recurrence
;
Retrospective Studies*
;
Stomach
4.Gastroprotective Effects of Glutinous Rice Extract against Ethanol-, Indomethacin-, and Stress-induced Ulcers in Rats
Dong Up SONG ; Mi Sun JANG ; Hyun Woo KIM ; Hyun Joong YOON ; Kee Oh CHAY ; Young Eun JOO ; Young Do JUNG ; Sung Yeul YANG ; Bong Whan AHN
Chonnam Medical Journal 2014;50(1):6-14
This study was designed to evaluate the efficacy of an orally administered aqueous extract of glutinous rice (GRE) to protect against acute gastric mucosal lesions induced by ethanol, indomethacin, and water immersion restraint stress in rats and to characterize the active substances responsible for the protection. GRE was shown to dose-dependently prevent the gastric lesions induced by the above ulcerogenic treatments at doses of 30 to 300 mg/kg. GRE treatment increased the gastric mucin content and partially blocked the ethanol-induced depletion of the gastric mucus layer. Also, it increased the nonprotein sulfhydryl concentration in the gastric mucosa. The gastroprotective action of GRE was markedly enhanced by co-treatment with 4-8 mg/kg tea extracts. The activity of GRE was completely lost by heat treatment at 80degrees C for 3 min or treatment with 0.01% pepsin at 37degrees C for 1 h. Protein extraction studies indicated that prolamins are involved in the gastroprotective activity of GRE. Our results suggest that glutinous rice proteins are useful for the prevention and treatment of gastritis and peptic ulcer.
Animals
;
Ethanol
;
Gastric Mucins
;
Gastric Mucosa
;
Gastritis
;
Hot Temperature
;
Immersion
;
Indomethacin
;
Mucus
;
Pepsin A
;
Peptic Ulcer
;
Prolamins
;
Rats
;
Tea
;
Ulcer
;
Water
5.Efficacy and feasibility of laparoscopic subtotal cholecystectomy for acute cholecystitis.
In Oh JEONG ; Jang Yong KIM ; Yun Mee CHOE ; Sun Keun CHOI ; Yoon Seok HEO ; Keon Young LEE ; Sei Joong KIM ; Young Up CHO ; Seung Ik AHN ; Kee Chun HONG ; Kyung Rae KIM ; Seok Hwan SHIN
Korean Journal of Hepato-Biliary-Pancreatic Surgery 2011;15(4):225-230
BACKGROUNDS/AIMS: For patients with acute cholecystitis, conversion from laparoscopic cholecystectomy to open surgery is not uncommon due to possibilities of serious hemorrhage at the liver bed and bile duct injury. Recent studies reported successful laparoscopic subtotal cholecystectomy for acute cholecystitis. The purpose of this study was to determine the efficacy and feasibility of such an operation based on the experience of surgeons at our facility. METHODS: In this study, we enrolled 144 patients who had received either laparoscopic subtotal cholecystectomy (LSC), laparoscopic cholecystectomy (LC), or open cholecystectomy (OC) for acute cholecystitis from January 2004 to December 2009 at the Department of Surgery of our hospital. Their symptoms, signs, operative findings, pathologic results and postoperative results were compared and analyzed. RESULTS: There were 26 patients in the LSC group 80 in the LC group and 38 in the OC group. There were no differences in mean age, sex, and symptoms of acute cholecystitis. The LSC group showed higher CRP levels (p<0.001) and a higher grade according to the Tokyo criteria (p=0.001). The mean operative time was 115.6 minutes and mean blood loss was 158.9 ml without intra-operative or postoperative transfusion. There weren't any bile duct injuries during the operation. No group suffered bile leakage. Drains were removed 3.3 days after the operation in the LC group, the shortest time compared to the other groups (p<0.001). LC and LSC groups demonstrated shorter postoperative hospital days and time to diet resumption than the OC group (p<0.001). CONCLUSIONS: LSC appears to be a safe and effective treatment in cases of severe acute cholecystitis that require consideration of conversion to open surgery.
Bile
;
Bile Ducts
;
Cholecystectomy
;
Cholecystectomy, Laparoscopic
;
Cholecystitis, Acute
;
Conversion to Open Surgery
;
Diet
;
Hemorrhage
;
Humans
;
Liver
;
Operative Time
;
Tokyo
6.The Effect of Duodenojejunal Bypass for T2DM Patients Below BMI 25 kg/m2 in Early Postoperative Period.
In Ki HONG ; Jang Young KIM ; Yeon Ji LEE ; Yun Mee CHOE ; Sun Keun CHOI ; Keon Young LEE ; Sei Joong KIM ; Young Up CHO ; Seung Ik AHN ; Kee Chun HONG ; Seok Hwan SHIN ; Kyung Rae KIM ; Yoon Seok HEO
Journal of the Korean Surgical Society 2011;80(2):103-110
PURPOSE: Diabetes mellitus refers to one of several risk factors for cardiovascular diseases, renal failure and so on. Medical treatments of T2DM cannot suggest a perfect cure. But gastric bypass resulting in the exclusion of the duodenum and proximal jejunum has been shown to improve or resolve T2DM. The goal of this study is to evaluate the effect of duodenojejunal bypass for T2DM patients below BMI 25 kg/m2 in early postoperative period. METHODS: Duodenojejunal bypass was performed on 25 patients at Inha University Hospital from July 2009 to April 2010. We compared 75 g OGTT, insulin, C peptide to those 7 days postoperative. The definitions for improvement are serum glucose level below 200 mg/dl of 75 g OGTT at 120 min or below 200 mg/dl at every other time in spite of over 200 mg/dl at 120 min. RESULTS: A total of 25 patients (15 men and 10 women) were included. Median value BMI was 23.17 kg/m2 and the mean duration of T2DM was 8.3 years. There was a significant decrease of postoperative 75 g OGTT levels from 176, 268, 345, 373, 371 mg/dl to 125, 170, 200, 225 and 241 mg/dl, respectively (P<0.001). Only patients' age was an independent factor resolution of T2DM based on this study. CONCLUSION: Duodenojejunal bypass could be one viable treatment modality for improving or resolving of T2DM although these are early results. This study has preliminary meanings only and the results of longer follow-up and a larger number of patients are necessary, by which we should be able to determine the effect and indications for surgical treatment of T2DM.
C-Peptide
;
Cardiovascular Diseases
;
Diabetes Mellitus
;
Duodenum
;
Follow-Up Studies
;
Gastric Bypass
;
Glucose
;
Glucose Tolerance Test
;
Humans
;
Insulin
;
Jejunum
;
Male
;
Postoperative Period
;
Renal Insufficiency
;
Risk Factors
7.Transition of Treatment Modalities for Peripheral Arterial Occlusive Disease for the Recent 5 Years According to the TASC II Classifications in a Single Institution.
Won Pyo CHO ; Hye Jung CHA ; Eun Mi KONG ; Yong Sun JEON ; Soon Gu CHO ; Jang Yong KIM ; Kee Chun HONG ; Yoon Seok HEO ; Keon Young LEE ; Sei Joong KIM ; Young Up CHO ; Seung Ik AHN
Journal of the Korean Society for Vascular Surgery 2011;27(1):23-26
PURPOSE: Endovascular treatment for peripheral arterial obstructive disease (PAOD) is replacing traditional arterial bypass in the western world. Yet there are few reports to evaluate the pattern of clinical practice pattern for PAOD in Korea. This study was conducted to evaluate the treatment pattern for PAOD between endovascular treatment and arterial bypass, and to compare their clinical characteristics. METHODS: We conducted a retrospective study on the prospectively maintained database of patients who underwent endovascular treatment and arterial bypass for PAOD from March 2005 to December 2009 in Inha University Hospital. The aortoiliac lesions and femoropopliteal lesions were categorized by the Trans Atlantic Inter-Society Consensus (TASC) II classifications. Their treatments and clinical characteristics were compared between the former period (2005~2007 y) and the latter period (2008~2009 y). RESULTS: Three hundred nine cases (178 patients) were treated for PAOD by either arterial bypass or endovascular treatment. The patients' mean age was 69.1+/-11.3 year old. There was no difference in clinical characteristics between the two periods except for age. Endovascular treatments of both aortoiliac and femoropopliteal arterial lesions were increased in the latter period (P=0.023, P<0.001). Also, the endovascular treatments were increased in the TASC C and D aortoiliac and femoropopliteal lesions in the latter period (P=0.020, P<0.001). CONCLUSION: Endovascular treatment for PAOD is increasing in clinical practice and this shows feasibility in critically ill patient with TASC C and D lesions, although arterial bypass is still important.
Angioplasty
;
Arterial Occlusive Diseases
;
Atherosclerosis
;
Consensus
;
Critical Illness
;
Humans
;
Korea
;
Physician's Practice Patterns
;
Prospective Studies
;
Retrospective Studies
;
Western World
8.Management of Duodenal Perforations after Endoscopic Retrograde Cholangiopancreatography.
Jong Hyun KIM ; Keon Young LEE ; Seung Ik AHN ; Kee Chun HONG ; Seok JUNG ; Don Haeng LEE ; Yun Mee CHOE ; Sun Keun CHOI ; Yoon Seok HUR ; Sei Joong KIM ; Young Up CHO ; Seok Hwan SHIN ; Kyung Rae KIM
Korean Journal of Gastrointestinal Endoscopy 2011;42(2):83-89
BACKGROUND/AIMS: Surgery has been the mainstay of treatment for duodenal perforations after the introduction of endoscopic retrograde cholangiopancreatography (ERCP). Yet there have recently been arguments that conservative management with or without endoscopic intervention may be possible and safe. METHODS: For the patients who received ERCP at Inha University Hospital from Jan. 2001 to Dec. 2007, we retrospectively analyzed the clinical manifestations, the treatment and the clinical outcomes of the cases with duodenal perforation. RESULTS: Among the 1708 ERCP cases, duodenal perforation occurred in eleven (0.6%) patients. There were two cases of duodenal perforations (type I), four cases of peri-Vaterian injury (type II), two cases of bile duct perforations (type III) and three cases of retroperitoneal perforations (type IV). Six patients (55%) were treated surgically while the others were managed conservatively. Except for one death (9.1%), ten patients fully recovered. Either residual diseases or fluid collections, as seen on CT, were present in the surgically managed patients. The median time interval between ERCP and surgery was 19 hours (range: 8~30 hours). CONCLUSIONS: To decide on the management of duodenal perforation after ERCP, the presence of residual disease or the leakage of intraluminal contents should be considered along with the type of the perforation.
Bile Ducts
;
Cholangiopancreatography, Endoscopic Retrograde
;
Duodenum
;
Humans
;
Retrospective Studies
9.Inferior Vena Cava (IVC) Filter Retrieval Rates after Catheter Directed Thrombolysis or Pharmacomechanical Thrombectomy in Deep Vein Thrombosis (DVT) and Its Characteristics.
Hyo Keun NO ; Joong Suck KIM ; Jang Yong KIM ; Kyung Rae KIM ; Seok Hwan SHIN ; Seung Ik AHN ; Young Up CHO ; Sei Joong KIM ; Keon Young LEE ; Yoon Seok HUR ; Sun Keun CHOI ; Yun Mee CHOE ; Yong Sun JEON ; Soon Gu CHO ; Kee Chun HONG
Journal of the Korean Surgical Society 2010;79(6):497-502
PURPOSE: Inferior vena cava (IVC) filter is commonly practiced to prevent pulmonary embolism during endovascular therapy of deep vein thrombosis (EndoDVT). When the thrombus is trapped inside the filter during intervention, its removal is quite challenging. The purpose of this study is to determine retrieval rates of IVC filter after EndoDVT and its characteristics. METHODS: Patients who underwent EndoDVT in Inha Unversity Hospital from June 2004 to May 2009 were reviewed retrospectively. Retrievable IVC filter was inserted before EndoDVT. EndoDVT was done by catheter directed thrombolysis or pharmacomechanical thrombectomy using urokinase. IVC filter retrieval was decided according to computed tomography after 2 weeks. RESULTS: 126 patients were treated with EndoDVT. Optease (n=101) and Tulip (n=25) IVC filters were inserted. IVC filters were retrieved in 42.9% (54/126). There was no IVC filter related complication during its insertion and removal. IVC filter was not retrieved in 72 patients. Reasons for its failure include residual thrombosis in IVC filter (n=28), high risk for recurrent DVT (n=34), massive pulmonary embolism (n=8), and death (n=2). Residual thrombus inside IVC filter disappeared in 5 patients during 6-month follow up. CONCLUSION: IVC filters retrieval rate after EndoDVT was 42.9%. This can be improved by thorough patient follow up and extended retrievability.
Catheters
;
Follow-Up Studies
;
Humans
;
Pulmonary Embolism
;
Retrospective Studies
;
Thrombectomy
;
Thrombosis
;
Tulipa
;
Urokinase-Type Plasminogen Activator
;
Vena Cava Filters
;
Vena Cava, Inferior
;
Venous Thrombosis
10.Clinical Experience with Hirschsprung's Disease.
Keunmyoung PARK ; Yun Mee CHOE ; Jang Young KIM ; Sun Keun CHOI ; Yoon Seok HEO ; Keon Young LEE ; Sei Joong KIM ; Young Up CHO ; Seung Ik AHN ; Kee Chun HONG ; Seok Hwan SHIN ; Kyung Rae KIM ; Jeong Meen SEO
Journal of the Korean Association of Pediatric Surgeons 2010;16(2):162-169
The aim of this study is to review our clinical experience with patients with Hirschsprung's disease (HD) Medical records of 39 children who underwent definitive surgery for HD at Inha University Hospital from September 1996 to June 2008 were analyzed by age at presentation, sex, gestational age, birth weight, clinical presentation, diagnostic tools, level of aganglionosis, surgical procedures, postoperative complications, and postoperative bowel function. Twenty-five patients (64.1%) were males and 14 (35.9%) were females. Thirty patients (76.9%) were diagnosed and treated in the neonatal period. The transitional zone was at the rectosigmoid region in 89.7%. Twenty-seven patients (69%) were treated by preliminary colostomy or ileostomy. Twenty-four patients had the Duhamel operation, 6 patients anorectal myectomy, and 9 patients had transanal endorectal pull-through (TEP). Five of 9 patients who had the TEP procedure did laparoscopic assistance. Postoperatively, seventeen patients (83%) passed stool once or more times per day and 3 patients had stool soiling. This study demonstrated that the majority of the patients had good results. To determine which treatment is most effective comparative review by operation method would be required.
Birth Weight
;
Child
;
Colostomy
;
Female
;
Gestational Age
;
Hirschsprung Disease
;
Humans
;
Ileostomy
;
Male
;
Medical Records
;
Postoperative Care
;
Pyrazines
;
Soil

Result Analysis
Print
Save
E-mail